Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Improvements in tummy and bowel symptoms after short and longer term Elexacaftor / Tezacaftor / Ivacaftor therapy (ETI)

Improvements in tummy and bowel symptoms after short and longer term Elexacaftor / Tezacaftor / Ivacaftor therapy (ETI)

Resource Type

CF Research News

Authors

L.R. Caley , L. Gillgrass , C. Zagoya, H. Saumtally, F. Duckstein, H. White, J.G. Mainz, D.G. Peckham

References

J Cyst Fibros. 2025 Jan 14:S1569-1993(25)00010-4. doi: 10.1016/j.jcf.2025.01.010.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFAbd-Score [3]
Elexacaftor/tezacaftor/ivacaftor (ETI) therapy [4]
Gastrointestinal symptoms [5]
abdominal [6]

Date

Tuesday, January 14, 2025

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/improvements-tummy-and-bowel-symptoms-after-short-and-longer-term

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-24-00610R1_FINAL_Peckham_090224_0.pdf [2] https://pubmed.ncbi.nlm.nih.gov/39814671/ [3] https://www.ecfs.eu/research-article-keywords/cfabd-score [4] https://www.ecfs.eu/research-article-keywords/elexacaftortezacaftorivacaftor-eti-therapy [5] https://www.ecfs.eu/research-article-keywords/gastrointestinal-symptoms [6] https://www.ecfs.eu/research-article-keywords/abdominal [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines